By Adam Bonislawski
A metabolite-based diagnostic developed by researchers at the Georgia Institute of Technology identified women with ovarian cancer with 100 percent accuracy in a recently published 94-subject trial.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.
Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.
In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.
An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.